These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10430759)

  • 21. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene.
    Gurunluoglu R; Ozer K; Skugor B; Lubiatowski P; Carnevale K; Siemionow M
    Ann Plast Surg; 2002 Aug; 49(2):161-9. PubMed ID: 12187344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector.
    Magovern CJ; Mack CA; Zhang J; Hahn RT; Ko W; Isom OW; Crystal RG; Rosengart TK
    Ann Thorac Surg; 1996 Aug; 62(2):425-33; discussion 433-4. PubMed ID: 8694601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions.
    Crystal RG; Harvey BG; Wisnivesky JP; O'Donoghue KA; Chu KW; Maroni J; Muscat JC; Pippo AL; Wright CE; Kaner RJ; Leopold PL; Kessler PD; Rasmussen HS; Rosengart TK; Hollmann C
    Hum Gene Ther; 2002 Jan; 13(1):65-100. PubMed ID: 11779413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease.
    Yang ZJ; Zhang YR; Chen B; Zhang SL; Jia EZ; Wang LS; Zhu TB; Li CJ; Wang H; Huang J; Cao KJ; Ma WZ; Wu B; Wang LS; Wu CT
    Mol Biol Rep; 2009 Jul; 36(6):1323-9. PubMed ID: 18649012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo.
    Mühlhauser J; Merrill MJ; Pili R; Maeda H; Bacic M; Bewig B; Passaniti A; Edwards NA; Crystal RG; Capogrossi MC
    Circ Res; 1995 Dec; 77(6):1077-86. PubMed ID: 7586219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
    Rajagopalan S; Mohler E; Lederman RJ; Saucedo J; Mendelsohn FO; Olin J; Blebea J; Goldman C; Trachtenberg JD; Pressler M; Rasmussen H; Annex BH; Hirsch AT;
    Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions.
    Harvey BG; Maroni J; O'Donoghue KA; Chu KW; Muscat JC; Pippo AL; Wright CE; Hollmann C; Wisnivesky JP; Kessler PD; Rasmussen HS; Rosengart TK; Crystal RG
    Hum Gene Ther; 2002 Jan; 13(1):15-63. PubMed ID: 11779412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmyocardial laser revascularization combined with vascular endothelial growth factor 121 (VEGF121) gene therapy for chronic myocardial ischemia--do the effects really add up?
    Heilmann CA; Attmann T; von Samson P; Göbel H; Marmé D; Beyersdorf F; Lutter G
    Eur J Cardiothorac Surg; 2003 Jan; 23(1):74-80. PubMed ID: 12493508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation.
    Schwarz ER; Speakman MT; Patterson M; Hale SS; Isner JM; Kedes LH; Kloner RA
    J Am Coll Cardiol; 2000 Apr; 35(5):1323-30. PubMed ID: 10758976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus vector-mediated transfer of the vascular endothelial growth factor cDNA to healing abdominal fascia enhances vascularity and bursting strength in mice with normal and impaired wound healing.
    Ailawadi M; Lee JM; Lee S; Hackett N; Crystal RG; Korst RJ
    Surgery; 2002 Feb; 131(2):219-27. PubMed ID: 11854705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study.
    Mäkinen K; Manninen H; Hedman M; Matsi P; Mussalo H; Alhava E; Ylä-Herttuala S
    Mol Ther; 2002 Jul; 6(1):127-33. PubMed ID: 12095313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.
    Kornowski R; Leon MB; Fuchs S; Vodovotz Y; Flynn MA; Gordon DA; Pierre A; Kovesdi I; Keiser JA; Epstein SE
    J Am Coll Cardiol; 2000 Mar; 35(4):1031-9. PubMed ID: 10732905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEGF gene therapy for coronary artery disease and peripheral vascular disease.
    Rasmussen HS; Rasmussen CS; Macko J
    Cardiovasc Radiat Med; 2002; 3(2):114-7. PubMed ID: 12699842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
    Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
    Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
    Su H; Lu R; Kan YW
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: moving on down the road.
    Patterson C; Runge MS
    Circulation; 2000 Aug; 102(9):940-2. PubMed ID: 10961953
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiogenesis for revascularization of ischaemic tissues.
    Isner JM
    Eur Heart J; 1997 Jan; 18(1):1-2. PubMed ID: 9049503
    [No Abstract]   [Full Text] [Related]  

  • 38. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia.
    Gowdak LH; Poliakova L; Wang X; Kovesdi I; Fishbein KW; Zacheo A; Palumbo R; Straino S; Emanueli C; Marrocco-Trischitta M; Lakatta EG; Anversa P; Spencer RG; Talan M; Capogrossi MC
    Circulation; 2000 Aug; 102(5):565-71. PubMed ID: 10920070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization.
    Sayeed-Shah U; Mann MJ; Martin J; Grachev S; Reimold S; Laurence R; Dzau V; Cohn LH
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):763-9. PubMed ID: 9806383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor.
    Magovern CJ; Mack CA; Zhang J; Rosengart TK; Isom OW; Crystal RG
    Hum Gene Ther; 1997 Jan; 8(2):215-27. PubMed ID: 9017425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.